Skip to content

Depression: all studies

Page 323 of 1,034: studies 3,221 to 3,230 of 10,336, newest first. Back to the depression overview

Research

Sudarshan Kriya Yogic Breathing in the Treatment of Stress, Anxiety, and Depression: Part II—Clinical Applications and Guidelines

The Journal of Alternative and Complementary Medicine August 1, 2005 Richard P. Brown, Patricia L. Gerbarg 470 citations

Yogic breathing is a unique method for balancing the autonomic nervous system and influencing psychologic and stress-related disorders. Part I of this series presented a neurophysiologic theory of the effects of Sudarshan Kriya Yoga (SKY). Part II will review clinical studies, our own clinical observations, and guidelines for the safe and effective use of yoga breath techniques in a wide range...

Ketamine Induces Dopamine-Dependent Depression of Evoked Hippocampal Activity in the Nucleus Accumbens in Freely Moving Rats

Journal of Neuroscience January 12, 2005 Mark J. Hunt, Karima Kessal, Rene Garcia

Noncompetitive NMDA receptor antagonists, such as ketamine, induce a transient schizophrenia-like state in healthy individuals and exacerbate psychosis in schizophrenic patients. In rodents, noncompetitive NMDA receptor antagonists induce a behavioral syndrome that represents an experimentally valid model of schizophrenia. Current experimental evidence has implicated the nucleus accumbens in...

Relationship between ecstasy use and depression: a study controlling for poly-drug use.

Psychopharmacology May 2004 Jonathan P. Roiser, Barbara J. Sahakian

3,4-Methylenedioxymethamphetamine (MDMA or "ecstasy") causes serotonin neuron damage in laboratory animals. The serotonin system is known to be important in the regulation of mood. Previous research has shown that MDMA users score higher on self-report ratings of depression than controls. However, MDMA users commonly take other illicit substances and many studies do not fully control for...

Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects.

Journal of Consulting and Clinical Psychology 2004 S. Helen Ma, John D. Teasdale 1,401 citations

Recovered recurrently depressed patients were randomized to treatment as usual (TAU) or TAU plus mindfulness-based cognitive therapy (MBCT). Replicating previous findings, MBCT reduced relapse from 78% to 36% in 55 patients with 3 or more previous episodes; but in 18 patients with only 2 (recent) episodes corresponding figures were 20% and 50%. MBCT was most effective in preventing relapses not...

REM sleep reduction, mood regulation and remission in untreated depression.

Psychiatry Research December 1, 2003 Rosalind Cartwright, Erin Baehr, Jennifer Kirkby et al.

The contribution of increased rapid eye movement (REM) pressure through repeated, mild, reduction of (REM) sleep to remission from untreated depression was studied over a 5-month period in 20 depressed and 10 control volunteers. Sixty percent of the depressed subjects were in remission at the end of the study. Sixty-four percent of the variance in remission could be accounted for by four...

Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.

Journal of Neuroscience June 15, 2003 Alexander F. Hoffman, Murat Oz, Tara Caulder et al.

The rewarding properties of the psychoactive constituents of marijuana, termed "cannabinoids," may reflect actions on synaptic transmission in the nucleus accumbens (NAc). Furthermore, long-term changes in these synapses may support the addictive process. Excitatory and inhibitory synapses are acutely inhibited by cannabinoids in the NAc, and endogenous cannabinoids (endocannabinoids) play a...

Metacognitive awareness and prevention of relapse in depression: Empirical evidence.

Journal of Consulting and Clinical Psychology 2002 John D. Teasdale, Richard G. Moore, Hazel Hayhurst et al. 966 citations

Metacognitive awareness is a cognitive set in which negative thoughts/feelings are experienced as mental events, rather than as the self. The authors hypothesized that (a) reduced metacognitive awareness would be associated with vulnerability to depression and (b) cognitive therapy (CT) and mindfulness-based CT (MBCT) would reduce depressive relapse by increasing metacognitive awareness. They...

DOI: 10.1037//0022-006x.70.2.275 (opens in new tab) Metacognition Mindfulness-based cognitive therapy Clinical psychology Depression economics +3

Therapeutic Effects of Buddhism's Sasimsagwan Meditation on Reducing Depression of Nursing Students

Journal of Korean Academy of Psychiatric and Mental Health Nursing June 30, 2001 Yeon Ja Choi

According to a discipline of Buddhist philosophy, cognitive understanding is believed to be based above all on the name (general concept) under the assumption that understanding is controlled by language. Hence, the discipline proposes Sasimsagwan (a thorough and deep insight on 4 things, i.e. name, thing, one's real nature and difference) as a means to free the subjects from the fixed language...

A qualitative study of mindfulness‐based cognitive therapy for depression

British Journal of Medical Psychology June 1, 2001 Oliver J Mason, Isabel Hargreaves 242 citations

Psychotherapeutic interventions containing training in mindfulness meditation have been shown to help participants with a variety of somatic and psychological conditions. Mindfulness-based cognitive therapy (MBCT) is a meditation-based psychotherapeutic intervention designed to help reduce the risk of relapse of recurrent depression. There is encouraging early evidence from multi-centre...